Jane Street
LENZ

Jane Street’s LENZ Therapeutics LENZ Stock Holding History

Jane Street’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,847
Closed -$658K – 13223
2025
Q4 		$750K Buy
46,847
+37,060
+379% +$1.08M ﹤0.01% 6784
2025
Q3 		$456K Buy
+9,787
New +$360K ﹤0.01% 8060
2025
Q1 		– Sell
-7,938
Closed -$229K – 10864
2024
Q4 		$229K Sell
7,938
-4,089
-34% -$125K ﹤0.01% 8180
2024
Q3 		$286K Buy
+12,027
New +$267K ﹤0.01% 8110
2024
Q1 		– Sell
-4,599
Closed -$84.3K – 10228
2023
Q4 		$84.3K Buy
+4,599
New +$75.9K ﹤0.01% 8647
2023
Q2 		– Sell
-7,954
Closed -$136K – 9716
2023
Q1 		$136K Buy
+7,954
New +$129K ﹤0.01% 8069
2022
Q4 		– Sell
-1,649
Closed -$37K – 10305
2022
Q3 		$37K Buy
+1,649
New +$39.3K ﹤0.01% 9036
2022
Q1 		– Sell
-5,980
Closed -$520K – 11147
2021
Q4 		$520K Buy
+5,980
New +$495K ﹤0.01% 7189
2021
Q3 		– Sell
-2,175
Closed -$468K – 10885
2021
Q2 		$468K Buy
+2,175
New +$379K ﹤0.01% 7372

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Jane Street's LENZ Position: Q1 2026 in Review

Jane Street sold out of LENZ Therapeutics (LENZ) in Q1 2026, closing a stake of 46,847 shares — an estimated $658K sold.

Jane Street first reported a position in LENZ in Q2 2021 and held it in 9 quarters. The position peaked at $750K in Q4 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Jane Street reported no remaining LENZ Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 46,847 LENZ Therapeutics shares in Q1 2026, an estimated $658K.
  • Jane Street first reported a position in LENZ Therapeutics in Q2 2021 and held it in 9 quarters.
  • Jane Street's LENZ Therapeutics position peaked at $750K in Q4 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.